Examples could include the use of modulators to manipulate S1P1-β-arrestin-G-protein complex, S1P1-Receptor Tyrosine Kinase complex and HDL-S1P signaling in pathogenic conditions such as auto-immune disease, cardiovascular disease and cancer. Here, MBTPS1 is linked to cardiovascular disorder.